These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1418413)

  • 41. Soluble CD30 (sCD30) and effectiveness of leukocyte therapy in recurrent pregnancy loss patients.
    Gharesi-Fard B; Zolghadri J; Haghbin H
    J Reprod Immunol; 2013 Apr; 97(2):240-4. PubMed ID: 23394737
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The prognostic value of anti-paternal antibodies and leukocyte immunizations on the proportion of live births in couples with consecutive recurrent miscarriages.
    Orgad S; Loewenthal R; Gazit E; Sadetzki S; Novikov I; Carp H
    Hum Reprod; 1999 Dec; 14(12):2974-9. PubMed ID: 10601081
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Recurring spontaneous abortion: rational basis of immunotherapy. Bibliographic review].
    Candiani GB; Acaia B; Ricciardiello O; Sciorelli G; Illeni MT; Marelli G; Vignali M
    Ann Ostet Ginecol Med Perinat; 1987; 108(2):128-34. PubMed ID: 3307592
    [No Abstract]   [Full Text] [Related]  

  • 44. [Immunological treatment of spontaneous repeated abortions. The value of transfusing the partner's leukocytes in the third week of gestation].
    Sagot P; Bignon JD; Cesbron A; Laurent FX; Adjou C; Muller JY
    J Gynecol Obstet Biol Reprod (Paris); 1993; 22(5):471-5. PubMed ID: 7693793
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Infertility treated with donor specific lymphocytes in recurrent idiopathic spontaneous abortion.
    Bernstein IL; Bernstein DI; Balakrishnan K; Korbee L
    Transplant Proc; 1989 Feb; 21(1 Pt 1):565. PubMed ID: 2705234
    [No Abstract]   [Full Text] [Related]  

  • 46. Immunotherapy and recurrent abortion: a randomized clinical trial.
    Illeni MT; Marelli G; Parazzini F; Acaia B; Bocciolone L; Bontempelli M; Faden D; Fedele L; Maffeis A; Radici E
    Hum Reprod; 1994 Jul; 9(7):1247-9. PubMed ID: 7962426
    [TBL] [Abstract][Full Text] [Related]  

  • 47. What's a mother to do? Analysis of trials evaluating new treatments for unexplained recurrent miscarriages and other complaints.
    Cowchock S
    Am J Reprod Immunol; 1991 Dec; 26(4):156-9. PubMed ID: 1840731
    [No Abstract]   [Full Text] [Related]  

  • 48. On reaching the tunnel at the end of the light.
    Horwitz RI; Singer BH; Makuch RW; Viscoli CM
    J Clin Epidemiol; 1997 Jul; 50(7):753-5. PubMed ID: 9253384
    [No Abstract]   [Full Text] [Related]  

  • 49. Neonatal thrombocytopenia as side effect of immunotherapy for recurrent spontaneous abortion.
    Deligiannidis A; Parapanissiou E; Mavroudi A; Papastavrou T
    Am J Reprod Immunol; 2007 Mar; 57(3):167-8. PubMed ID: 17295894
    [No Abstract]   [Full Text] [Related]  

  • 50. [Results of immunization with allogenic leukocytes in women with recurrent pregnancy loss].
    Radysh TV; Pysarieva SP; Chernyshov VP
    Lik Sprava; 2005; (1-2):52-5. PubMed ID: 15915992
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of anti-lymphocyte antibodies by flow cytometry or microlymphocytotoxicity in women with recurrent spontaneous abortions immunized with paternal leukocytes.
    Gilman-Sachs A; Luo SP; Beer AE; Beaman KD
    J Clin Lab Immunol; 1989 Oct; 30(2):53-9. PubMed ID: 2534916
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Allogenic leukocyte immunization after five or more miscarriages. Recurrent Miscarriage Immunotherapy Trialists Group.
    Carp HJ; Toder V; Torchinsky A; Portuguese S; Lipitz S; Gazit E; Mashiach S
    Hum Reprod; 1997 Feb; 12(2):250-5. PubMed ID: 9070705
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intravenous immune globulin in recurrent abortion.
    Heine O; Mueller-Eckhardt G
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):39-42. PubMed ID: 8033433
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Design and statistical issues in multicenter trials of severe head injury.
    Choi SC; Bullock R
    Neurol Res; 2001; 23(2-3):190-2. PubMed ID: 11320598
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induction of MLR-Bf and protection of fetal loss: a current double blind randomized trial of paternal lymphocyte immunization for women with recurrent spontaneous abortion.
    Pandey MK; Agrawal S
    Int Immunopharmacol; 2004 Feb; 4(2):289-98. PubMed ID: 14996420
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Immunotherapy by B-lymphocytes in patients with unexplained habitual abortion].
    Zhu G; Zhou Y; Ning B
    Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):212-3. PubMed ID: 11776161
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transfusion-related risks of intradermal allogeneic lymphocyte immunotherapy: single cases in a large cohort and review of the literature.
    Kling C; Steinmann J; Flesch B; Westphal E; Kabelitz D
    Am J Reprod Immunol; 2006 Sep; 56(3):157-71. PubMed ID: 16911711
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Large-scale randomized evidence: large, simple trials and overviews of trials.
    Peto R; Collins R; Gray R
    J Clin Epidemiol; 1995 Jan; 48(1):23-40. PubMed ID: 7853045
    [No Abstract]   [Full Text] [Related]  

  • 59. Immunotherapy for recurrent pregnancy loss: "standard of care or buyer beware".
    Hill JA
    J Soc Gynecol Investig; 1997; 4(6):267-73. PubMed ID: 9408880
    [No Abstract]   [Full Text] [Related]  

  • 60. Influence of histocompatibility antigens in recurrent spontaneous abortion and its relevance to leukocyte immunotherapy.
    Kilpatrick DC; Liston WA
    Hum Reprod; 1993 Oct; 8(10):1645-9. PubMed ID: 8300821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.